Chronic Symptoms and Pulmonary Dysfunction in Post-tuberculosis Brazilian Patients
Overview
Authors
Affiliations
Background: Questionnaire and spirometry were applied to post-tuberculosis indigenous and non-indigenous individuals from Dourados, Brazil, to investigate the prevalence of chronic respiratory symptoms and pulmonary dysfunction.
Methods: This was a cross-sectional study in cured tuberculosis individuals as reported in the National System on Reportable Diseases (SINAN) from 2002 to 2012.
Results: One hundred and twenty individuals were included in the study and the prevalence of chronic respiratory symptoms was 45% (95% CI, 34-59%). Respiratory symptoms included cough (28%), sputum (23%), wheezing (22%) and dyspnea (8%). These symptoms were associated with alcoholism, AOR: 3.1 (1.2-8.4); less than 4 years of schooling, AOR: 5.0 (1.4-17.7); and previous pulmonary diseases, AOR: 5.4 (1.7-17.3). Forty-one percent (95% CI, 29-56) had pulmonary disorders, of which the most prevalent were obstructive disorders (49%), followed by obstructive disorder with reduced forced vital capacity disorders (46%) and restrictive disorders (5%). The lifestyle difference could not explain differences in chronic symptoms and/or the prevalence of pulmonary dysfunction.
Conclusion: The high prevalence of chronic respiratory symptoms and pulmonary dysfunction in post-tuberculosis patients indicates a need for further interventions to reduce social vulnerability of patients successfully treated for tuberculosis.
Wang J, Yu L, Yang Z, Shen P, Sun Y, Shui L Int J Epidemiol. 2025; 54(2).
PMID: 39993264 PMC: 11849956. DOI: 10.1093/ije/dyae174.
Risk factors associated with post-tuberculosis sequelae: a systematic review and meta-analysis.
Akalu T, Clements A, Liyew A, Gilmour B, Murray M, Alene K EClinicalMedicine. 2024; 77:102898.
PMID: 39502524 PMC: 11535315. DOI: 10.1016/j.eclinm.2024.102898.
Taylor J, Bastos M, Lachapelle-Chisholm S, Mayo N, Johnston J, Menzies D EClinicalMedicine. 2023; 59:101979.
PMID: 37205923 PMC: 10189364. DOI: 10.1016/j.eclinm.2023.101979.
Ivanova O, Hoffmann V, Lange C, Hoelscher M, Rachow A Eur Respir Rev. 2023; 32(168).
PMID: 37076175 PMC: 10113954. DOI: 10.1183/16000617.0221-2022.
Martinez L, Gray D, Botha M, Nel M, Chaya S, Jacobs C Am J Respir Crit Care Med. 2023; 207(8):1080-1088.
PMID: 36746196 PMC: 10112440. DOI: 10.1164/rccm.202208-1543OC.